Experimental PET Tracer Separates Bacterial Infection from Sterile Inflammation in Mice
Published in Journals, Scanners and Imaging, Tools.
October 6, 2026
A study published on October 5 in Nature Biomedical Engineering describes a PET tracer designed to detect bacterial metabolism directly. The experimental compound, β-Me-2-[18F]FDG, is derived from fluorodeoxyglucose and exploits a bacterial carbohydrate transport pathway absent from mammalian cells.
Laboratory testing showed uptake by clinically relevant gram-positive bacteria, including Staphylococcus species, alongside stability in human serum and limited accumulation in mammalian cells.
In mouse infection models, the tracer produced signals more than six times higher at sites of live infection than in non-infected tissue. It did not accumulate in the tested sterile inflammation model and allowed researchers to monitor responses to antibiotics.
Targeting pathogens rather than the host inflammatory response could help address a limitation of conventional FDG imaging. However, these results come from laboratory and animal experiments. Human diagnostic accuracy, safety and clinical usefulness remain to be established; the study does not show a broadly validated test for all bacterial infections.
Source: Lee and colleagues, Nature Biomedical Engineering, published October 5, 2026. DOI: 10.1038/s41551-026-01798-1.